Varda Farooqui

A Review on Vadadustat: Hope in Treatment of Anemia Patients Having Chronic Kidney Disease

Nikita Gupta, Mohd Naveed Khan, Varda Farooqui, Guntoju Poojitha & Thipparam Kavya · Asian Journal of Immunology · 2024

Vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, may offer an oral alternative to injectable erythropoiesis-stimulating agents (ESAs) to treat anemia in patients undergoing peritoneal dialysis. Current standard of care for anemia linked to chronic kidney disea...

Open access Research Article 10.9734/aji/2024/v7i1153

A review on Iguratimod: Bridging Hope for Arthritis Patients through the Dual Power of Immunomodulation and Anti-inflammation

Nikita Gupta, Sana Begum, Varda Farooqui, Summaiya Afreen & Pranitha Avunoori · Asian Journal of Immunology · 2024

Iguratimod is a small novel compound considered as a disease-modifying anti-rheumatic drug (DMARD), which exhibits anti-inflammatory and immunomodulatory effects. Iguratimod acts directly on B cells by inhibiting the production of inflammatory cytokines (tumor necrosis factor-α,...

Open access Research Article 10.9734/aji/2024/v7i1132